S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SLNO Soleno Therapeutics Inc

58.34

0.00 (0.00%)

Pre Market

Last Updated: 03:05:46

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Soleno Therapeutics Charts.

Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Soleno Therapeutics Charts.

Soleno Therapeutics Inc News

Form 8-K - Current report
Tuesday 26 November 2024 (22 hours ago) • Edgar (US Regulatory)

Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
Tuesday 26 November 2024 (22 hours ago) • GlobeNewswire Inc.

Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024
Thursday 14 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 12 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Wednesday 6 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Soleno Therapeutics to Participate in Upcoming November Investor Conferences
Monday 28 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 24 October 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Monday 21 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 21 October 2024 (1 month ago) • Edgar (US Regulatory)

More Soleno Therapeutics Inc News Articles

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions